Compas Logo
Back

Knows about the use of disease modifying anti-rheumatic drugs (DMARDs) in RA

Level

This learning outcome is a secondary level outcome.

This primary outcome(s) associated with this is (are):

Sessions

This learning outcome is taught in the following sessions:

Assessment

This learning outcome is assessed in the following ways:

  • MBBS Pt 3 (Yr 3)

Barts and The London - School of Medicine and Dentistry

© 2011 Barts and The London
School of Medicine and Dentistry

Mobile design and development by Studio 24